INS and type 2 diabetes mellitus: Patients are scared of hypoglycemia, which represents the main concern also for diabetologists: it has been estimated that 57.9% of patients with T2D reduce their insulin dose after the onset of severe hypoglycemia [6] and 79.1% of physicians indicate that the risk of hypoglycemia prevents them from initiating more aggressive treatment [2].